| NVAX Snapshot | |
|---|---|
| Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company is headquartered in Gaithersburg, Maryland. | |
| VALUATION DATA | |
| Market Capitalization | $2,025 | Price to Sales | 3.00 |
| Earnings per Share | $0.0000 |
| PE Ratio | 407506000 |
| PRICE DATA | |
| Most Recent Close | $7.9600 |
| 52 Week High | $2.585 |
| 52 Week Low | $1.198 |
| 50-Day Moving Average | $34.36 |
| 200-Day Moving Average | $0.843 |
| All data are from Alpha Vantage as of today. For more infomation on NVAX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search